Lipocine's LPCN 1144 Met Non-Alcoholic Steatohepatitis ("NASH") Resolution Regulatory Endpoint in Phase 2 LiFT StudyPRNewsWire • 08/25/21
Lipocine Announces Presentations at The International Liver Congress™ 2021 Digital EventPRNewsWire • 06/23/21
Lipocine To Start Testing Neuro-Steroid Candidate In Postpartum Depression PatientsBenzinga • 06/14/21
Clarus Therapeutics Defeats Lipocine's Patent Infringement Lawsuit On Summary JudgmentPRNewsWire • 05/26/21
Lipocine To Present At M Vest / Maxim Conference And At The Lytham Partners ConferencePRNewsWire • 03/11/21
Lipocine Announces USPTO Declaration Of Interference Between Lipocine And Clarus Patent ApplicationsPRNewsWire • 01/14/21
Lipocine Announces Update on Jury Trial in Patent Infringement Lawsuit Against Clarus TherapeuticsPRNewsWire • 12/29/20
Lipocine: Imminent Catalysts In NASH And Oral Testosterone Replacement Therapy Make For A Strong BuySeeking Alpha • 12/14/20